Neoplasm Treatment - Ireland
Ireland- The Neoplasm Treatment market in Ireland is expected to witness significant growth in the coming years.
- According to projections, the revenue in this market is projected to reach US$564.70m by 2024.
- This growth is expected to continue with an annual growth rate (CAGR 2024-2029) of 3.18%, resulting in a market volume of US$660.50m by 2029.
- When compared to other countries globally, it is worth noting that United States is expected to generate the highest revenue in this market.
- In 2024, the revenue United States is projected to be US$90.56bn.
- This indicates the dominance of the United States in the Neoplasm Treatment market.
- Ireland's neoplasm treatment market is witnessing a surge in innovative therapies and research collaborations with leading international cancer institutes.
Definition:
Neoplasm Treatment refers to the medical and surgical treatments of cancer patients who require hospitalization for their care. This includes surgeries, chemotherapy, radiation therapy, immunotherapy, and/or other treatments that require close monitoring and support from healthcare professionals. Patients will typically stay in a hospital for several days to several weeks, depending on the severity of their condition. This allows hospitals to provide the highest level of medical support and to help manage symptoms and/or side effects of the patients while they receive treatment.
Additional information:
The Neoplasm Treatments market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Inpatient treatment of cancer patients
Out-Of-Scope
- Long-term rehabilitative care
- Home-based rehabilitative care
